Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP391127.RAHpPVvV3hGH62_CMDuqF2qUw9nXYtKXIexOq__FcfoE8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP391127.RAHpPVvV3hGH62_CMDuqF2qUw9nXYtKXIexOq__FcfoE8130_assertion type Assertion NP391127.RAHpPVvV3hGH62_CMDuqF2qUw9nXYtKXIexOq__FcfoE8130_head.
- NP391127.RAHpPVvV3hGH62_CMDuqF2qUw9nXYtKXIexOq__FcfoE8130_assertion description "[hI-con1 molecule induces strong cytotoxicity against primary chemotherapy-resistant ovarian cancer cell lines overexpressing TF and may represent a novel therapeutic agent for the treatment of ovarian tumors refractory to standard treatment modalities.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP391127.RAHpPVvV3hGH62_CMDuqF2qUw9nXYtKXIexOq__FcfoE8130_provenance.
- NP391127.RAHpPVvV3hGH62_CMDuqF2qUw9nXYtKXIexOq__FcfoE8130_assertion evidence source_evidence_literature NP391127.RAHpPVvV3hGH62_CMDuqF2qUw9nXYtKXIexOq__FcfoE8130_provenance.
- NP391127.RAHpPVvV3hGH62_CMDuqF2qUw9nXYtKXIexOq__FcfoE8130_assertion SIO_000772 21725665 NP391127.RAHpPVvV3hGH62_CMDuqF2qUw9nXYtKXIexOq__FcfoE8130_provenance.
- NP391127.RAHpPVvV3hGH62_CMDuqF2qUw9nXYtKXIexOq__FcfoE8130_assertion wasDerivedFrom befree-20150227 NP391127.RAHpPVvV3hGH62_CMDuqF2qUw9nXYtKXIexOq__FcfoE8130_provenance.
- NP391127.RAHpPVvV3hGH62_CMDuqF2qUw9nXYtKXIexOq__FcfoE8130_assertion wasGeneratedBy ECO_0000203 NP391127.RAHpPVvV3hGH62_CMDuqF2qUw9nXYtKXIexOq__FcfoE8130_provenance.